Catalyst Wire Dossier Catalyst Wire Dossier

Ivermectin Cream 1%

ivermectin · Zydus Worldwide DMCC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ivermectin Cream 1%, covering 2020-10-14 to 2020-10-14. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea [Phase 3]

See pricing